(Q42258301)

19 October 2017

Expansion of recipient-derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation (English)

1 reference

19 October 2017

S Borchers

1

1 reference

19 October 2017

E M Weissinger

2

1 reference

19 October 2017

B Pabst

3

1 reference

19 October 2017

T Ganzenmueller

4

1 reference

19 October 2017

E Dammann

5

1 reference

19 October 2017

S Luther

6

1 reference

19 October 2017

H Diedrich

7

1 reference

19 October 2017

A Ganser

8

1 reference

19 October 2017

M Stadler

9

1 reference

19 October 2017

19 June 2013

1 reference

Transplant Infectious Disease

19 October 2017

1 reference

19 October 2017

15

1 reference

19 October 2017

6

1 reference

19 October 2017

627-633

1 reference

Cytomegalovirus infection/disease after hematopoietic stem cell transplantation

19 October 2017

1 reference

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

21 January 2018

1 reference

Clinical aspects of CMV infection after stem cell transplantation

21 January 2018

1 reference

CMV-specific T cell therapy

21 January 2018

1 reference

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

21 January 2018

1 reference

Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study

21 January 2018

1 reference

Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group

21 January 2018

1 reference

How and when should we monitor chimerism after allogeneic stem cell transplantation?

21 January 2018

1 reference

Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis.

21 January 2018

1 reference

Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen

21 January 2018

1 reference

Polyfunctional responses by human T cells result from sequential release of cytokines

21 January 2018

1 reference

Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT.

21 January 2018

1 reference

Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation

21 January 2018

1 reference

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

21 January 2018

1 reference

Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues

21 January 2018

1 reference

Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TID.12101

1 reference

19 October 2017

1 reference